Abstract:Background and Aims. Screening for gastric diseases in symptomatic outpatients with conventional esophagogastroduodenoscopy (C-EGD) is expensive and has poor compliance. We aimed to explore the efficiency and safety of magnetic-controlled capsule gastroscopy (MCCG) in symptomatic outpatients who refused C-EGD. Methods. We performed a retrospective study of 76794 consecutive symptomatic outpatients from January 2014 to October 2019. A total of 2318 adults (F/M=1064/1254) in the MCCG group who refused C-EGD were matched with adults in the C-EGD group using propensity-score matching (PSM). The detection rates of abnormalities were analyzed to explore the application of MCCG in symptomatic patients. Results. Our study demonstrated a prevalence of gastric ulcers (GUs) in patients with functional dyspepsia- (FD-) like symptoms of 8.14%. The detection rate of esophagitis and Barrett’s esophagus was higher in patients with typical gastroesophageal reflux disease (GERD) symptoms than in patients in the other four groups (P<0.01). The detection rates of gastric ulcers in the five groups (abdominal pain, bloating, heartburn, follow-up, and bleeding) were significantly different (P=0.015). The total detection rate of gastric ulcers in symptomatic patients was 9.7%. A total of 7 advanced carcinomas were detected by MCCG and confirmed by endoscopic or surgical biopsy. The advanced gastric cancer detection rate was not significantly different between the MCCG group and the C-EGD matched group in terms of nonhematemesis GI bleeding (2 vs. 2, P=1.00). In addition, the overall focal lesion detection rate in the MCCG group was superior to that in the C-EGD matched group (224 vs. 184, P=0.038). MCCG gained a clinically meaningful small bowel diagnostic yield of 54.8% (17/31) out of 31 cases of suspected small bowel bleeding. No patient reported capsule retention at the two-week follow-up. Conclusion. MCCG is well tolerated, safe, and technically feasible and has a considerable diagnostic yield. The overall gastric diagnostic yield of gastric focal lesions with MCCG was comparable to that with C-EGD. MCCG offered a supplementary diagnosis in patients who had a previously undiagnostic C-EGD, indicating that MCCG could play an important role in the routine monitoring and follow-up of outpatient. MCCG shows its safety and efficiency in symptomatic outpatient applications.

Clinical application of magnetically controlled capsule gastroscopy in gastric disease diagnosis: recent advances

The future of magnetically controlled capsule gastroscopy.

The Application of Magnetic-Controlled Capsule Gastroscopy in Patients Refusing C-EGD: A Single-Center 5-Year Observational Study

Second-generation magnetically controlled capsule gastroscopy with improved image resolution and frame rate: a randomized controlled clinical trial (with video)

Magnetic-controlled capsule endoscopy vs. gastroscopy for gastric diseases: a two-center self-controlled comparative trial

Accuracy of Magnetically Controlled Capsule Endoscopy, Compared with Conventional Gastroscopy, in Detection of Gastric Diseases.

Application of small-sized magnetically controlled capsule gastroscopy in upper gastrointestinal diseases screening in asymptomatic individuals

A Systematic Review on Diagnosis and Treatment of Gastrointestinal Diseases by Magnetically Controlled Capsule Endoscopy and Artificial Intelligence

Screening for upper gastrointestinal cancers with magnetically controlled capsule gastroscopy: a feasibility study

Comparison between the widely used magnetically controlled capsule gastroscopy and conventional gastroscopy: a meta-analysis

The standardized training and assessment system for magnetically controlled capsule gastroscopy (with video)

Sa2054 the Clinical Utility of Magnetically Controlled Capsule Endoscopy in Pediatric Patients

PROSPECTIVE, MULTICENTER, SELF-CONTROLLED CLINICAL TRIAL ON THE EFFECTIVENESS AND SAFETY OF A NOVEL CABLE-TRANSMISSION MAGNETICALLY CONTROLLED CAPSULE ENDOSCOPE SYSTEM FOR THE EXAMINATION OF UPPER GASTROINTESTINAL DISEASES

Clinical guideline on magnetically controlled capsule gastroscopy (2021 edition)

Prospective, multicenter, self-controlled clinical trial on the effectiveness and safety of cable-transmission magnetically controlled capsule endoscope system for the examination of upper gastrointestinal diseases

Use of artificial intelligence for detection of gastric lesions by magnetically controlled capsule endoscopy

Magnetically controlled capsule endoscopy as the first-line examination for high-risk patients for the standard gastroscopy: a preliminary study

Detachable string magnetically controlled capsule endoscopy for the noninvasive diagnosis of esophageal diseases: A prospective, blind clinical study

Tu1088 DOES MAGNETIC-CONTROLLED CAPSULE GASTROSCOPY HAVE DIAGNOSTIC VALUE IN PATIENTS WITH REFLUX OR HEARTBURN?

Magnetic-assisted capsule endoscopy in the upper GI tract by using a novel navigation system (with video)

Screening value for gastrointestinal lesions of magnetic-controlled capsule endoscopy in asymptomatic individuals